ENVIVA INC (EVA)
US29415B1035 - Common Stock
We assign a fundamental rating of 2 out of 10 to EVA. EVA was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. EVA may be in some trouble as it scores bad on both profitability and health. EVA has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year EVA has reported negative net income.
EVA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EVA reported negative net income in multiple years.
Of the past 5 years EVA 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of EVA (-11.74%) is worse than 91.55% of its industry peers.
With a Return On Equity value of -109.62%, EVA is not doing good in the industry: 94.37% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.74% | ||
| ROE | -109.62% | ||
| ROIC | N/A |
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 1.44%, EVA is doing worse than 84.98% of the companies in the same industry.
In the last couple of years the Gross Margin of EVA has declined.
The Profit Margin and Operating Margin are not available for EVA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.44% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%
2. Health
2.1 Basic Checks
EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EVA has been increased compared to 1 year ago.
Compared to 5 years ago, EVA has more shares outstanding
EVA has a better debt/assets ratio than last year.
2.2 Solvency
EVA has an Altman-Z score of 0.16. This is a bad value and indicates that EVA is not financially healthy and even has some risk of bankruptcy.
EVA has a worse Altman-Z score (0.16) than 70.89% of its industry peers.
EVA has a Debt/Equity ratio of 5.83. This is a high value indicating a heavy dependency on external financing.
EVA has a worse Debt to Equity ratio (5.83) than 92.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.83 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.16 |
ROIC/WACCN/A
WACC3.19%
2.3 Liquidity
A Current Ratio of 1.42 indicates that EVA should not have too much problems paying its short term obligations.
EVA has a Current ratio (1.42) which is in line with its industry peers.
EVA has a Quick Ratio of 1.06. This is a normal value and indicates that EVA is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.06, EVA perfoms like the industry average, outperforming 53.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The earnings per share for EVA have decreased strongly by -68.50% in the last year.
Looking at the last year, EVA shows a decrease in Revenue. The Revenue has decreased by -0.20% in the last year.
Measured over the past years, EVA shows a quite strong growth in Revenue. The Revenue has been growing by 15.04% on average per year.
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-936.36%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Revenue growth Q2Q-1.55%
3.2 Future
EVA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.17% yearly.
EVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.60% yearly.
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue Next Year-5.43%
Revenue Next 2Y3.2%
Revenue Next 3Y10.15%
Revenue Next 5Y10.6%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EVA indicates a slightly more expensive valuation: EVA is more expensive than 78.87% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 95.7 |
4.3 Compensation for Growth
A more expensive valuation may be justified as EVA's earnings are expected to grow with 14.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.01%
EPS Next 3Y14.13%
5. Dividend
5.1 Amount
No dividends for EVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ENVIVA INC
NYSE:EVA (5/17/2024, 7:04:00 PM)
After market: 0.6 +0.02 (+4.33%)0.5751
0 (-0.84%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap42.84M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.74% | ||
| ROE | -109.62% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 1.44% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.83 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-148.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y